Design Therapeutics Inc (DSGN)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | GOVER, JUSTIN D. | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jun 9, 2026 | SHAPIRO, DAVID | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jun 9, 2026 | SCHMID, JOHN P. | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jun 9, 2026 | BERGER, HEATHER A. | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jun 9, 2026 | LAPPE, RODNEY W | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jun 9, 2026 | GEORGE, SIMEON | Director, 10% Owner | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Mar 31, 2026 | SHAPIRO, DAVID | Director | Stock option (right to buy) | Acquisition | 60,000 | 0 |
| Mar 31, 2026 | SHAPIRO, DAVID | Director | Stock option (right to buy) | Acquisition | 7,500 | 0 |
| Jan 2, 2026 | STORGARD, CHRIS | Chief Medical Officer | Stock option (right to buy) | Acquisition | 250,000 | 0 |
| Jan 2, 2026 | GOVER, JUSTIN D. | Director | Stock option (right to buy) | Acquisition | 45,000 | 0 |
| Jan 2, 2026 | JEFFRIES, SEAN | Chief Operating Officer | Stock option (right to buy) | Acquisition | 375,000 | 0 |
| Jan 2, 2026 | BURGESS, JULIE | Chief Accounting Officer | Stock option (right to buy) | Acquisition | 150,000 | 0 |
| Jan 2, 2026 | SHAH, PRATIK | Director, President, CEO and Chairperson | Stock option (right to buy) | Acquisition | 750,000 | 0 |
| Dec 9, 2025 | SHAH, PRATIK | Director, President, CEO and Chairperson | Stock option (right to buy) | Acquisition | 525,000 | 0 |